Eli Lilly claims B12 in compounded GLP-1s creates an impurity. We break down what the data shows, what's missing, and whether you should worry.
Medicare covers Wegovy and Zepbound for $50/month starting July 2026. Learn who qualifies, what it costs, and how to prepare for the GLP-1 Bridge.
Protect your muscle mass on a GLP-1 medication with these 7 beginner bodyweight exercises you can do at home in 10 minutes.
GLP-1 microdosing for longevity is trending. We break down the science, what microdosing really means, and whether the evidence supports it.
A Stanford study of 5,000+ GLP-1 users found that small behavior changes make a real difference. Here are the 8 microsteps and how to start.
GLP-1 medications like Ozempic and Wegovy can reduce appetite and lead to nutritional gaps. Here is what the research says and how to stay protected.
The FDA warned Novo Nordisk for not reporting deaths and serious side effects tied to its GLP-1 medications. Here is what happened.
Products marketed as "natural GLP-1s" and peptide supplements are everywhere. Here is what the science says and how to protect yourself.
New research links GLP-1 medications to reduced addiction risk. See what the WashU and JAMA studies found and what clinical trials are underway.
Research shows weight regain after stopping Ozempic or Wegovy. See how fast it happens, what else reverses, and what you can do now to keep results.
See what a full day of eating looks like on a GLP-1 with protein, fiber, and carb targets. Sample meals, macros, and tips for Ozempic users.
Novo Nordisk and Hims struck a deal on Ozempic and Wegovy pricing. See what it means for GLP-1 costs, compounded access, and your options.
